Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zaniboni

Showing results (111-120 of 233) with videos related to

Pageof 24
Sort By:
Future Oncology (London, England)|January 19, 2021
Appropriateness of trifluridine/tipiracil in the clinical practice of third-line therapy in metastatic colorectal cancerCarlo Barone, Maria Di Bartolomeo, Sara Lonardi, et al.
Cancer|June 28, 2007
First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancerMaria Giulia Zampino, Elena Magni, Cristian Massacesi, et al.
Surgery Today|January 3, 2021
Red blood cell transfusions and the survival in patients with cancer undergoing curative surgery: a systematic review and meta-analysisFausto Petrelli, Michele Ghidini, Antonio Ghidini, et al.
American Journal of Clinical Oncology|August 8, 2006
Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC)Luigi Cavanna, Fabrizio Artioli, Claudio Codignola, et al.
Cancer Chemotherapy and Pharmacology|May 12, 2012
FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II studyAlberto Zaniboni, Enrico Aitini, Sandro Barni, et al.
Tumori|July 22, 2017
Significance of neutrophil-to-lymphocyte ratio in Western advanced EGFR-mutated non-small cell lung cancer receiving a targeted therapyFausto Meriggi, Claudio Codignola, Giordano D Beretta, et al.
Cancers|August 17, 2019
Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational StudiesFausto Petrelli, Michele Ghidini, Antonio Ghidini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 14, 2012
Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients. A pilot studyFederica Andreis, Marco Ferri, Maria Mazzocchi, et al.
Reviews on Recent Clinical Trials|April 18, 2015
Gemcitabine Plus Nab-Paclitaxel as Second-Line and Beyond Treatment for Metastatic Pancreatic Cancer: a Single Institution Retrospective AnalysisPaola Bertocchi, Chiara Abeni, Fausto Meriggi, et al.
Current Problems in Cancer|April 12, 2024
Platinum dose in neoadjuvant therapy for triple-negative breast cancer: A systematic review and network meta-analysisFausto Petrelli, Antonio Ghidini, Carmen Rea, et al.
Pageof 24

Showing results (111-120 of 233) with videos related to

Sort By:
Pageof 24
Future Oncology (London, England)|January 19, 2021
Appropriateness of trifluridine/tipiracil in the clinical practice of third-line therapy in metastatic colorectal cancerCarlo Barone, Maria Di Bartolomeo, Sara Lonardi, et al.
Cancer|June 28, 2007
First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancerMaria Giulia Zampino, Elena Magni, Cristian Massacesi, et al.
Surgery Today|January 3, 2021
Red blood cell transfusions and the survival in patients with cancer undergoing curative surgery: a systematic review and meta-analysisFausto Petrelli, Michele Ghidini, Antonio Ghidini, et al.
American Journal of Clinical Oncology|August 8, 2006
Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC)Luigi Cavanna, Fabrizio Artioli, Claudio Codignola, et al.
Cancer Chemotherapy and Pharmacology|May 12, 2012
FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II studyAlberto Zaniboni, Enrico Aitini, Sandro Barni, et al.
Tumori|July 22, 2017
Significance of neutrophil-to-lymphocyte ratio in Western advanced EGFR-mutated non-small cell lung cancer receiving a targeted therapyFausto Meriggi, Claudio Codignola, Giordano D Beretta, et al.
Cancers|August 17, 2019
Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational StudiesFausto Petrelli, Michele Ghidini, Antonio Ghidini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 14, 2012
Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients. A pilot studyFederica Andreis, Marco Ferri, Maria Mazzocchi, et al.
Reviews on Recent Clinical Trials|April 18, 2015
Gemcitabine Plus Nab-Paclitaxel as Second-Line and Beyond Treatment for Metastatic Pancreatic Cancer: a Single Institution Retrospective AnalysisPaola Bertocchi, Chiara Abeni, Fausto Meriggi, et al.
Current Problems in Cancer|April 12, 2024
Platinum dose in neoadjuvant therapy for triple-negative breast cancer: A systematic review and network meta-analysisFausto Petrelli, Antonio Ghidini, Carmen Rea, et al.
Pageof 24